Dr. Hering joined Sensient in September 1994 as a senior research scientist. He has initiated, developed and finalized successful new products, both market-driven and customer-driven. In April 2007, he was appointed to his present position.
Dr. Hering completed his post-doctoral training at Oxford University in microbiology. He received a doctorate in pathology from the University of Wisconsin, Madison, and a bachelor's degree from the University of Colorado at Boulder.
"I am pleased to congratulate Dr. Hering on his election," said Kenneth P. Manning, chairman and CEO of Sensient Technologies. "His research and management expertise and his service to the company have contributed to Sensient's ongoing success."